Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Talk outline
- LSD synthesis & discovery of psychedelic effects
- Physiological effects and use
- The scientific utility of LSD
- Study of psychoactive drugs
- G protein-coupled receptors (GPCRs)
- GPCR signaling
- Ligand pharmacology
- Structural and functional determinants of LSD
- 5-HT2B receptor structure
- X-ray structure of LSD bound 5-HT2B receptor
- Chemical structure of the ergoline scaffold
- Binding poses of LSD & ergotamine
- Structure of LSD and receptor-bound LSD
- Studying the function of LSD diethylamide
- Diethylamide moiety drives LSD pharmacology
- Why is LSD so potent?
- LSD’s dissociation from 5-HT receptors
- EL2 forms a lid that interacts with LSD
- L209 mutation and lid flexibility
- L209A mutation and affinity
- L209A mutation and LSD’s binding kinetics
- The same effects are observed at 5-HT2A
- Functional implications of LSD's off- & on-rates
- L209A mutation does not affect 5-HT signaling
- LSD’s functional selectivity is time dependent
- Identical effects are observed at 5-HT2A
- Implications for LSD signaling
- Future directions
- Acknowledgements
Topics Covered
- Lysergic Acid Diethylamide (LSD) history, physiological effects, and utility
- G Protein-coupled serotonin receptor signalling
- Structure of LSD-bound serotonin receptor
- Uniquely slow LSD binding kinetics
- Binding kinetics are linked to LSD’s pharmacological properties
Links
Series:
Categories:
Talk Citation
Wacker, D. (2019, July 31). Structural basis of LSD signaling [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 12, 2024, from https://doi.org/10.69645/RHSB2197.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Daniel Wacker has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: G Protein-Coupled Receptors (GPCRs) Signaling in Health and Disease
Transcript
Please wait while the transcript is being prepared...
0:00
Hello everyone, and thank you for listening in to my talk.
My name is Daniel Wacker,
I am currently an Assistant Professor in
the Department of Pharmacological Sciences and
the Department of Neuroscience at the Icahn School of Medicine at Mount Sinai.
I'm mostly interested in molecular studies of psychoactive drugs,
and so the talk that I'll be giving today will
be about the structural basis of LSD signaling.
0:26
So on Slide 2, I outline the talk in a little bit of detail.
I will start out with giving a brief introduction into the history,
the effects and the potential future applications of LSD,
before we'll go into their molecular targets which
psychedelics usually act via G protein-coupled receptors or GPCRs,
and elicit cellular signals that then ultimatively cause the physiological responses.
So our studies are mostly on
these structural and functional aspects of LSD, and in particular,
I will be talking about the detailed interactions between chemical LSD and its receptors,
and what the pharmacological properties of LSD signaling are in molecular detail,
how it elicits the types of signals it elicits, and lastly,
what are the molecular mechanisms of LSD's long-lasting psychedelic effects.
That's something that's been known for some time,
but the underlying molecular principles
haven't been known until we've elucidated the structure.
Then I will very briefly summarize my talk,
and provide a brief overview of the future directions of this type of research.
1:38
So LSD was originally synthesized and discovered by this Swiss chemist,
Albert Hofmann in 1938 working in Switzerland at the time,
and it was more of a serendipitous find of what LSD actually caused.
So it was a chemical synthesized as a series of derivatives and originally,
it was termed LSD-25 because it was the 25th in a series of lysergic acid derivatives.
So what I've shown here on the left,
is the chemical structure of LSD.
I will go a little bit more into detail later on.
So Albert Hofmann discovered the psychedelic effects of LSD in April 16,1943,
which was effectively the day where he opened the vial and
I think spilled a little bit of LSD on himself,
and on his way home,
he noticed what is now known as an altered state of conscious.
So he experienced effectively the first LSD trip in history.
A few days later, he repeated this experiment, so to speak,
with a much larger dose of LSD in the state to this day known as Bicycle Day.